Vericel to Present at Upcoming Investor Conferences
September 23 2015 - 4:15PM
Vericel Corporation (NASDAQ:VCEL), a leading developer of
patient-specific expanded cellular therapies for the treatment of
severe diseases and conditions, today announced that it will
present at the following investor conferences in late September and
early October:
- Ladenburg Thalmann 2015 Healthcare Conference at the Sofitel
Hotel in New York on Tuesday, September 29; Vericel's president and
CEO Nick Colangelo will present a corporate update at 10:00 a.m.
EDT. A live webcast of the presentation will be accessible through
the news and events section of the company's website or can be
accessed here: http://wsw.com/webcast/ladenburg/vcel
- The Stem Cell Meeting on the Mesa at the Estancia La Jolla
Hotel in La Jolla, CA on Wednesday October 7; Vericel's CSO Ross
Tubo, Ph.D., will present a corporate update at 5:45 p.m. PDT.
A live webcast of the presentation will be accessible through
the news and events section of the company's website or can be
accessed here: http://stemcellmeetingonthemesa.com/webcast/
About Vericel Corporation
Vericel Corporation (formerly Aastrom Biosciences, Inc.) is a
leader in developing patient-specific expanded cellular therapies
for use in the treatment of patients with severe diseases and
conditions. The company markets two autologous cell therapy
products in the United States: Carticel® (autologous cultured
chondrocytes), an autologous chondrocyte implant for the treatment
of cartilage defects in the knee, and Epicel® (cultured epidermal
autografts), a permanent skin replacement for the treatment of
patients with deep-dermal or full-thickness burns comprising
greater than or equal to 30 percent of total body surface area.
Vericel is also developing MACI™, a third-generation
autologous chondrocyte implant for the treatment of cartilage
defects in the knee, and ixmyelocel-T, a patient-specific
multicellular therapy for the treatment of advanced heart failure
due to ischemic dilated cardiomyopathy. For more information,
please visit the company's website at www.vcel.com.
CONTACT: Chad Rubin
The Trout Group
crubin@troutgroup.com
(646) 378-2947
or
Lee Stern
The Trout Group
lstern@troutgroup.com
(646) 378-2922
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Sep 2023 to Sep 2024